EBOS Group（EBOS.F）株式概要EBOSグループ・リミテッドは、オーストラリア、東南アジア、ニュージーランドにおいて、ヘルスケア、医療、医薬品、アニマルケア製品のマーケティング、卸売、販売を行っている。 詳細EBOS.F ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長1/6過去の実績2/6財務の健全性6/6配当金4/6報酬当社が推定した公正価値より30.6%で取引されている 収益は年間10.08%増加すると予測されています リスク分析株式の流動性は非常に低い 4.15%の配当は利益で十分にカバーされていない 過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見るEBOS.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$23.7581.3% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture016b2016201920222025202620282031Revenue AU$15.8bEarnings AU$276.7mAdvancedSet Fair ValueView all narrativesEBOS Group Limited 競合他社Henry ScheinSymbol: NasdaqGS:HSICMarket cap: US$8.3bCardinal HealthSymbol: NYSE:CAHMarket cap: US$46.7bCencoraSymbol: NYSE:CORMarket cap: US$51.5bMcKessonSymbol: NYSE:MCKMarket cap: US$90.7b価格と性能株価の高値、安値、推移の概要EBOS Group過去の株価現在の株価NZ$23.7552週高値NZ$23.7552週安値NZ$20.02ベータ0.181ヶ月の変化0%3ヶ月変化n/a1年変化n/a3年間の変化n/a5年間の変化n/aIPOからの変化13.02%最新ニュースお知らせ • Feb 25+ 1 more updateEBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025. EBOS Group Limited (NZSE:EBO) completed the acquisition of unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025.お知らせ • Jan 22EBOS Group Limited to Report First Half, 2026 Results on Feb 25, 2026EBOS Group Limited announced that they will report first half, 2026 results on Feb 25, 2026お知らせ • Aug 28EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired Next Generation Pet Foods Pty Ltd for AUD 43 million on July 1, 2025. A cash consideration of AUD 43 million will be paid by EBOS Group Limited. As part of consideration, AUD 43 million is paid towards common equity of Next Generation Pet Foods Pty Ltd. The deal was fully funded through existing debt facilities and cash on hand. The transaction is expected to be marginally EPS accretive in the first year. EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd on July 1, 2025.お知らせ • Aug 15EBOS Group Limited, Annual General Meeting, Oct 29, 2025EBOS Group Limited, Annual General Meeting, Oct 29, 2025. Location: at the park hyatt hotel, 99 halsey street, auckland New Zealandお知らせ • Jun 03EBOS Group Limited to Report Fiscal Year 2025 Results on Aug 27, 2025EBOS Group Limited announced that they will report fiscal year 2025 results on Aug 27, 2025お知らせ • May 12EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million.EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,600,000 Price\Range: AUD 33.92最新情報をもっと見るRecent updatesお知らせ • Feb 25+ 1 more updateEBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025. EBOS Group Limited (NZSE:EBO) completed the acquisition of unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025.お知らせ • Jan 22EBOS Group Limited to Report First Half, 2026 Results on Feb 25, 2026EBOS Group Limited announced that they will report first half, 2026 results on Feb 25, 2026お知らせ • Aug 28EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired Next Generation Pet Foods Pty Ltd for AUD 43 million on July 1, 2025. A cash consideration of AUD 43 million will be paid by EBOS Group Limited. As part of consideration, AUD 43 million is paid towards common equity of Next Generation Pet Foods Pty Ltd. The deal was fully funded through existing debt facilities and cash on hand. The transaction is expected to be marginally EPS accretive in the first year. EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd on July 1, 2025.お知らせ • Aug 15EBOS Group Limited, Annual General Meeting, Oct 29, 2025EBOS Group Limited, Annual General Meeting, Oct 29, 2025. Location: at the park hyatt hotel, 99 halsey street, auckland New Zealandお知らせ • Jun 03EBOS Group Limited to Report Fiscal Year 2025 Results on Aug 27, 2025EBOS Group Limited announced that they will report fiscal year 2025 results on Aug 27, 2025お知らせ • May 12EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million.EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,600,000 Price\Range: AUD 33.92お知らせ • Apr 11EBOS Group Limited has completed a Follow-on Equity Offering in the amount of NZD 217.220005 million.EBOS Group Limited has completed a Follow-on Equity Offering in the amount of NZD 217.220005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,926,876 Price\Range: NZD 36.65 Discount Per Security: NZD 0.69635 Transaction Features: Regulation S; Subsequent Direct Listingお知らせ • Apr 10+ 1 more updateEBOS Group Limited has filed a Follow-on Equity Offering in the amount of NZD 217.220005 million.EBOS Group Limited has filed a Follow-on Equity Offering in the amount of NZD 217.220005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,926,876 Price\Range: NZD 36.65 Discount Per Security: NZD 0.69635 Transaction Features: Regulation S; Subsequent Direct Listingお知らせ • Jan 31EBOS Group Limited Announces Appointment of Coline Mcconville as A Director, Effective 1 February 2025EBOS Group Limited announced the appointment of Coline Mcconville as A Director, Effective 1 February 2025.お知らせ • Jan 22EBOS Group Limited Appoints Grant Viney as Chief Executive Officer of EBOS Animal Care , Effective 1 February 2025EBOS Group Limited announced the appointment of Mr. Grant Viney to the role of Chief Executive Officer of EBOS Animal Care with effect from 1 February 2025. Mr. Viney is currently the Executive General Manager of EBOS-owned Masterpet, having joined the business in 2019. The business, which includes premium natural pet food brand, Black Hawk, and the Vitapet food and treats range, has experienced strong and consistent growth under Mr. Viney's management. Before joining EBOS, Mr. Viney held senior roles at leading FMCG companies including Accolade Wines, PZ Cussons, Dairy Farmers Australia and Mars Confectionary.お知らせ • Jan 14EBOS Group Limited to Report First Half, 2025 Results on Jan 19, 2025EBOS Group Limited announced that they will report first half, 2025 results on Jan 19, 2025お知らせ • Jan 03EBOS Group Limited Appoints Matthew Muscio as DirectorEBOS Group Limited announced the appointment of Matthew Muscio as director. Date of appointment is 1 January 2025.お知らせ • Oct 23+ 1 more updateEBOS Group Limited Announces the Retirement of Peter Williams as DirectorEBOS Group Limited announced that with the Board's renewal process, independent director, Peter Williams, will retire with effect from the conclusion of meeting.お知らせ • Aug 23EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024EBOS Group Limited announced final dividend of NZD 0.61500000 per share. Dividend Payment Date is 18 September 2024. Record Date is 30 August 2024. Ex-Date is 29 August 2024.お知らせ • Apr 27EBOS Group Limited Announces Chief Financial Officer ChangesEBOS Group Limited announced the appointment of Alistair Gray to the role of Chief Financial Officer (CFO) with effect from 30 September 2024. Mr. Gray is currently Deputy CFO at Endeavour Group. Mr. Gray joined Endeavour Group in 2018 just prior to the demerger from Woolworths and is responsible for the Group finance teams. Prior to Endeavour he held senior roles at Toll Group, Mondelez International and Coles and throughout his career has accumulated a wealth of consumer, retail and supply chain experience across Australia, New Zealand, the UK and Asia. Mr. Gray will be based at company’ Melbourne office. In announcing Mr. Gray’s appointment, the company also announced that its current CFO, Leonard Hansen, will move from the CFO role and continue with the company in the capacity of Chief Risk Officer (CRO). Leonard Hansen will continue in the role of the company’s CFO until Mr. Gray’s commencement in September.お知らせ • Feb 21+ 1 more updateEBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024EBOS Group Limited announced that they will report fiscal year 2024 results on Aug 21, 2024お知らせ • Jan 10EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024EBOS Group Limited announced that they will report first half, 2024 results on Feb 21, 2024お知らせ • Dec 20EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million.EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million on December 19, 2023. The purchase price was funded from existing debt facilities and the transaction is expected to be immediately marginally EPS accretive. EBOS Group Limited (NZSE:EBO) completed the acquisition of additional 39% stake in Transmedic Pte Ltd. from TS Lee on December 19, 2023.お知らせ • Dec 15Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout TalkParagon Care Limited (ASX:PGC) is understood to have hired Rothschild & Co as a defence adviser amid chatter in the market it has been in the cross hairs of EBOS Group Limited (NZSE:EBO). There's talk in the market that Paragon has bidders interested in the business at 40c a share. Paragon Care shares closed up 2.3% to 22c on 13 December 2023. Earlier, Paragon had said that it had not received approaches from EBOS, while both groups declined to comment on 13 December 2023. Its market value is $147 million. As earlier reported by DataRoom, EBOS held talks about a backdoor listing involving Chemist Warehouse, but instead, the pharmacy giant embarked on the $8 billion-plus move through EBOS's rival Sigma Healthcare.お知らせ • Dec 07EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross PursuitEBOS Group Limited (NZSE:EBO) seems to be moving on quickly from its $4 billion courtship of Greencross Limited, with talk that it is eyeing Paragon Care Limited (ASX:PGC). While small, with just a $113.5 million market value, Paragon Care operates in the areas of specialty diagnostics and devices under brands such as Designs for Vision, Electro Medical Group, Specialist Medical Supplies and Immulab. Apparently, there's a large Asian private equity firm also interested in buying the business right now. However, should there be interest in Paragon it is likely to be early days, with sources close to the company saying it has not received approaches. Sources say the group has been yet to prove to the market it can deliver on its mergers and acquisition strategy. Other parties that have looked at Paragon in the past are Navis Capital, which now owns Device Technologies.お知らせ • Nov 24EBOS Not to Proceed with Acquisition in Animal Care SegmentNew Zealand EBOS Group Limited (NZSE:EBO) will not proceed with the potential transaction related to its animal care segment, the healthcare products distributor said on November 22, 2023. The announcement comes after local media reported the company would acquire TPG Capital-backed pets and vets business Greencross Limited.お知らせ • Sep 27EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023EBOS Group Limited announced Fully Franked Ordinary dividend for the six months ended June 30, 2023 of NZD 0.59514706 with Record Date 8 September, 2023; Ex Date 7 September, 2023 and Payment Date to be 29 September, 2023.お知らせ • Aug 23+ 1 more updateEbos Group Limited Announces Dividend, Payable on 29 September 2023EBOS Group Limited announced dividend of NZD $0.57000000. Record date is 08 September 2023. Ex-Date is 07 September 2023. Payment date is 29 September 2023.株主還元EBOS.FUS HealthcareUS 市場7D0%-2.8%-0.3%1Yn/a12.5%26.7%株主還元を見る業界別リターン: EBOS.FがUS Healthcare業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: EBOS.F US市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is EBOS.F's price volatile compared to industry and market?EBOS.F volatilityEBOS.F Average Weekly Movementn/aHealthcare Industry Average Movement7.6%Market Average Movement7.2%10% most volatile stocks in US Market16.2%10% least volatile stocks in US Market3.2%安定した株価: EBOS.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のEBOS.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト19225,770Adam Hallwww.ebosgroup.comEBOS Group Limitedは、オーストラリア、東南アジア、ニュージーランドにおいて、ヘルスケア、医療、医薬品、アニマルケア製品のマーケティング、卸売、販売を行っている。ヘルスケア事業とアニマルケア事業を展開。ヘルスケアロジスティクス、投薬管理ソリューション、薬局管理ソフトウェア、ロイヤルティ、ジェネリック、コンプライアンス、ビジネスインテリジェンス、店舗ソフトウェアサービス、ヘルスコミュニケーション、プログラム、コンサルタントサービスを提供。また、地域密着型のヘルスケアサービスやプログラム、ビタミン、ミネラル、サプリメント、ハーブティー、フルーツティー、天然歯磨き粉、糖蜜やマヌカハニーなどの機能性食品、独立薬局向けの5段階統合小売プログラム「ファーマシー・チョイス」、会員が小売ビジネスを推進するための地域薬局バナー「ヘルスセーブ」なども提供している。また、公立・私立病院、日帰り手術施設、一般診療所、高齢者介護施設、専門クリニック、政府機関、非営利医療機関向けに健康・ウェルネス製品、臨床上不可欠な製品を供給し、私立・公立病院、がんセンター、矯正施設、動物病院向けに薬局サービスを提供している。さらに、同種移植片ソリューション、ヘルスケア流通、倉庫管理、臨床試験管理、製品登録サービス、臨床試験ロジスティクス、美容医療機器、医療グレードの美容医療品、注射剤、手術機器、医療消耗品を提供している。さらに、ペット用栄養剤、おやつ、清掃用品、グルーミング用品および付属品の提供、コンパニオンアニマル、生産動物、馬術競技者向けの獣医学用品の卸売も行っている。以前はEarly Bros Dental & Surgical Supplies Ltd.として知られ、1986年にEBOS Group Limitedに社名を変更した。EBOSグループは1922年に設立され、本社はオーストラリアのドックランズにある。もっと見るEBOS Group Limited 基礎のまとめEBOS Group の収益と売上を時価総額と比較するとどうか。EBOS.F 基礎統計学時価総額US$3.54b収益（TTM）US$142.33m売上高(TTM)US$8.12b24.9xPER（株価収益率0.4xP/SレシオEBOS.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計EBOS.F 損益計算書（TTM）収益AU$12.27b売上原価AU$10.63b売上総利益AU$1.64bその他の費用AU$1.42b収益AU$215.14m直近の収益報告Jun 30, 2025次回決算日該当なし一株当たり利益（EPS）1.05グロス・マージン13.35%純利益率1.75%有利子負債／自己資本比率40.5%EBOS.F の長期的なパフォーマンスは？過去の実績と比較を見る配当金4.1%現在の配当利回り99%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/09/30 00:55終値2025/07/03 00:00収益2025/06/30年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋EBOS Group Limited 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。17 アナリスト機関Benjamin BrayshawBarrenjoey Markets Pty LimitedSaul HadassinBarrenjoey Markets Pty LimitedLyanne HarrisonBofA Global Research14 その他のアナリストを表示
お知らせ • Feb 25+ 1 more updateEBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025. EBOS Group Limited (NZSE:EBO) completed the acquisition of unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025.
お知らせ • Jan 22EBOS Group Limited to Report First Half, 2026 Results on Feb 25, 2026EBOS Group Limited announced that they will report first half, 2026 results on Feb 25, 2026
お知らせ • Aug 28EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired Next Generation Pet Foods Pty Ltd for AUD 43 million on July 1, 2025. A cash consideration of AUD 43 million will be paid by EBOS Group Limited. As part of consideration, AUD 43 million is paid towards common equity of Next Generation Pet Foods Pty Ltd. The deal was fully funded through existing debt facilities and cash on hand. The transaction is expected to be marginally EPS accretive in the first year. EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd on July 1, 2025.
お知らせ • Aug 15EBOS Group Limited, Annual General Meeting, Oct 29, 2025EBOS Group Limited, Annual General Meeting, Oct 29, 2025. Location: at the park hyatt hotel, 99 halsey street, auckland New Zealand
お知らせ • Jun 03EBOS Group Limited to Report Fiscal Year 2025 Results on Aug 27, 2025EBOS Group Limited announced that they will report fiscal year 2025 results on Aug 27, 2025
お知らせ • May 12EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million.EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,600,000 Price\Range: AUD 33.92
お知らせ • Feb 25+ 1 more updateEBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired an unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025. EBOS Group Limited (NZSE:EBO) completed the acquisition of unknown majority stake in MediAdvice Pty Ltd in the Second half of 2025.
お知らせ • Jan 22EBOS Group Limited to Report First Half, 2026 Results on Feb 25, 2026EBOS Group Limited announced that they will report first half, 2026 results on Feb 25, 2026
お知らせ • Aug 28EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd.EBOS Group Limited (NZSE:EBO) acquired Next Generation Pet Foods Pty Ltd for AUD 43 million on July 1, 2025. A cash consideration of AUD 43 million will be paid by EBOS Group Limited. As part of consideration, AUD 43 million is paid towards common equity of Next Generation Pet Foods Pty Ltd. The deal was fully funded through existing debt facilities and cash on hand. The transaction is expected to be marginally EPS accretive in the first year. EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd on July 1, 2025.
お知らせ • Aug 15EBOS Group Limited, Annual General Meeting, Oct 29, 2025EBOS Group Limited, Annual General Meeting, Oct 29, 2025. Location: at the park hyatt hotel, 99 halsey street, auckland New Zealand
お知らせ • Jun 03EBOS Group Limited to Report Fiscal Year 2025 Results on Aug 27, 2025EBOS Group Limited announced that they will report fiscal year 2025 results on Aug 27, 2025
お知らせ • May 12EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million.EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,600,000 Price\Range: AUD 33.92
お知らせ • Apr 11EBOS Group Limited has completed a Follow-on Equity Offering in the amount of NZD 217.220005 million.EBOS Group Limited has completed a Follow-on Equity Offering in the amount of NZD 217.220005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,926,876 Price\Range: NZD 36.65 Discount Per Security: NZD 0.69635 Transaction Features: Regulation S; Subsequent Direct Listing
お知らせ • Apr 10+ 1 more updateEBOS Group Limited has filed a Follow-on Equity Offering in the amount of NZD 217.220005 million.EBOS Group Limited has filed a Follow-on Equity Offering in the amount of NZD 217.220005 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,926,876 Price\Range: NZD 36.65 Discount Per Security: NZD 0.69635 Transaction Features: Regulation S; Subsequent Direct Listing
お知らせ • Jan 31EBOS Group Limited Announces Appointment of Coline Mcconville as A Director, Effective 1 February 2025EBOS Group Limited announced the appointment of Coline Mcconville as A Director, Effective 1 February 2025.
お知らせ • Jan 22EBOS Group Limited Appoints Grant Viney as Chief Executive Officer of EBOS Animal Care , Effective 1 February 2025EBOS Group Limited announced the appointment of Mr. Grant Viney to the role of Chief Executive Officer of EBOS Animal Care with effect from 1 February 2025. Mr. Viney is currently the Executive General Manager of EBOS-owned Masterpet, having joined the business in 2019. The business, which includes premium natural pet food brand, Black Hawk, and the Vitapet food and treats range, has experienced strong and consistent growth under Mr. Viney's management. Before joining EBOS, Mr. Viney held senior roles at leading FMCG companies including Accolade Wines, PZ Cussons, Dairy Farmers Australia and Mars Confectionary.
お知らせ • Jan 14EBOS Group Limited to Report First Half, 2025 Results on Jan 19, 2025EBOS Group Limited announced that they will report first half, 2025 results on Jan 19, 2025
お知らせ • Jan 03EBOS Group Limited Appoints Matthew Muscio as DirectorEBOS Group Limited announced the appointment of Matthew Muscio as director. Date of appointment is 1 January 2025.
お知らせ • Oct 23+ 1 more updateEBOS Group Limited Announces the Retirement of Peter Williams as DirectorEBOS Group Limited announced that with the Board's renewal process, independent director, Peter Williams, will retire with effect from the conclusion of meeting.
お知らせ • Aug 23EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024EBOS Group Limited announced final dividend of NZD 0.61500000 per share. Dividend Payment Date is 18 September 2024. Record Date is 30 August 2024. Ex-Date is 29 August 2024.
お知らせ • Apr 27EBOS Group Limited Announces Chief Financial Officer ChangesEBOS Group Limited announced the appointment of Alistair Gray to the role of Chief Financial Officer (CFO) with effect from 30 September 2024. Mr. Gray is currently Deputy CFO at Endeavour Group. Mr. Gray joined Endeavour Group in 2018 just prior to the demerger from Woolworths and is responsible for the Group finance teams. Prior to Endeavour he held senior roles at Toll Group, Mondelez International and Coles and throughout his career has accumulated a wealth of consumer, retail and supply chain experience across Australia, New Zealand, the UK and Asia. Mr. Gray will be based at company’ Melbourne office. In announcing Mr. Gray’s appointment, the company also announced that its current CFO, Leonard Hansen, will move from the CFO role and continue with the company in the capacity of Chief Risk Officer (CRO). Leonard Hansen will continue in the role of the company’s CFO until Mr. Gray’s commencement in September.
お知らせ • Feb 21+ 1 more updateEBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024EBOS Group Limited announced that they will report fiscal year 2024 results on Aug 21, 2024
お知らせ • Jan 10EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024EBOS Group Limited announced that they will report first half, 2024 results on Feb 21, 2024
お知らせ • Dec 20EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million.EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million on December 19, 2023. The purchase price was funded from existing debt facilities and the transaction is expected to be immediately marginally EPS accretive. EBOS Group Limited (NZSE:EBO) completed the acquisition of additional 39% stake in Transmedic Pte Ltd. from TS Lee on December 19, 2023.
お知らせ • Dec 15Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout TalkParagon Care Limited (ASX:PGC) is understood to have hired Rothschild & Co as a defence adviser amid chatter in the market it has been in the cross hairs of EBOS Group Limited (NZSE:EBO). There's talk in the market that Paragon has bidders interested in the business at 40c a share. Paragon Care shares closed up 2.3% to 22c on 13 December 2023. Earlier, Paragon had said that it had not received approaches from EBOS, while both groups declined to comment on 13 December 2023. Its market value is $147 million. As earlier reported by DataRoom, EBOS held talks about a backdoor listing involving Chemist Warehouse, but instead, the pharmacy giant embarked on the $8 billion-plus move through EBOS's rival Sigma Healthcare.
お知らせ • Dec 07EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross PursuitEBOS Group Limited (NZSE:EBO) seems to be moving on quickly from its $4 billion courtship of Greencross Limited, with talk that it is eyeing Paragon Care Limited (ASX:PGC). While small, with just a $113.5 million market value, Paragon Care operates in the areas of specialty diagnostics and devices under brands such as Designs for Vision, Electro Medical Group, Specialist Medical Supplies and Immulab. Apparently, there's a large Asian private equity firm also interested in buying the business right now. However, should there be interest in Paragon it is likely to be early days, with sources close to the company saying it has not received approaches. Sources say the group has been yet to prove to the market it can deliver on its mergers and acquisition strategy. Other parties that have looked at Paragon in the past are Navis Capital, which now owns Device Technologies.
お知らせ • Nov 24EBOS Not to Proceed with Acquisition in Animal Care SegmentNew Zealand EBOS Group Limited (NZSE:EBO) will not proceed with the potential transaction related to its animal care segment, the healthcare products distributor said on November 22, 2023. The announcement comes after local media reported the company would acquire TPG Capital-backed pets and vets business Greencross Limited.
お知らせ • Sep 27EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023EBOS Group Limited announced Fully Franked Ordinary dividend for the six months ended June 30, 2023 of NZD 0.59514706 with Record Date 8 September, 2023; Ex Date 7 September, 2023 and Payment Date to be 29 September, 2023.
お知らせ • Aug 23+ 1 more updateEbos Group Limited Announces Dividend, Payable on 29 September 2023EBOS Group Limited announced dividend of NZD $0.57000000. Record date is 08 September 2023. Ex-Date is 07 September 2023. Payment date is 29 September 2023.
